Advaxis/ US0076242082 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
02-20
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 ...
GlobeNewswire
2023-11-06
Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors
GlobeNewswire
2023-10-23
Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors a...
GlobeNewswire
2022-03-22
Phathom Pharmaceuticals Announces Appointment of Molly Henderson as Chief Financial and Business Off...
GlobeNewswire
2022-03-17
Advaxis Reports First Quarter Ended January 31, 2022 Financial Results and Provides a Business Updat...
GlobeNewswire
2022-02-14
Advaxis Reports Fiscal Year 2021 Financial Results and Provides a Business Update
GlobeNewswire
2022-02-08
Delisting of Securities of China XD Plastics Company Limited and Advaxis, Inc. from The Nasdaq Stock...
GlobeNewswire
2022-01-28
Advaxis Prices Offering of $5,000,000 of Convertible Redeemable Preferred Stock Through a Private Pl...
GlobeNewswire
2022-01-11
Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcomin...
GlobeNewswire
2021-12-17
Advaxis to Continue to Explore Additional Options to Maximize Stockholder Value
GlobeNewswire
2021-12-09
Advaxis Issues Letter to Stockholders Regarding Recent Special Meeting Results
GlobeNewswire
2021-11-24
Advaxis Issues Letter and Second Video Message to Stockholders Regarding Upcoming Special Meeting
GlobeNewswire
2021-11-22
Nasdaq Grants Advaxis, Inc. an Extension to December 20, 2021, to Complete Merger Transaction with B...
GlobeNewswire
2021-11-18
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Advaxis Stockholders V...
GlobeNewswire
2021-11-12
Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML
GlobeNewswire
2021-11-04
Advaxis Issues Letter and Video Message to Stockholders Regarding Upcoming Special Meeting
GlobeNewswire
2021-11-03
Leading Independent Proxy Advisory Firm ISS Recommends Advaxis Stockholders Vote “FOR” the Merger wi...
GlobeNewswire
2021-10-06
aTyr Pharma Announces Appointment of Robert W. Ashworth, PhD, as Vice President of Regulatory Affair...
GlobeNewswire
2021-09-10
Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update